Hatteras Venture Partners
Edit

Hatteras Venture Partners

http://www.hatterasvp.com/
Last activity: 23.06.2021
Hatteras Venture Partners is a venture capital firm that builds transformational companies in the areas of biopharmaceuticals, medical devices, diagnostics, healthcare IT, and related opportunities in human medicine. We typically invest in companies built on cutting-edge science from leading academic institutions. The firm has invested in companies across the United States in most of the major hotspots for health innovation. Given our headquarters location in RTP, NC, Hatteras plays a leadership role in building companies in North Carolina and the Southeastern United States, where technology is plentiful but resident venture capital is limited. Core to the mission of Hatteras Venture Partners is a belief that entrepreneurial innovation will create valuable new products that will transform the practice of medicine and create value for our investors. As entrepreneurs, operators, and investors, we are dedicated to the success of our companies and to the men and women who create them. Founded in 2000 and based in Durham, NC, the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to building successful new biomedical companies. The Hatteras team brings operational experience, a successful track record, and a proven ability to enhance the value of the companies in which it invests. With five funds, the firm has approximately $450 million under management. Hatteras is an Innovation to Impact sponsor of the Council for Entrepreneurial Development, a member of NCBIO, and an active volunteer in support of North Carolina and Southeast regional biotech activities.
Portfolio
1
Mentions
68
Location: United States, North Carolina, Durham
Employees: 11-50
Founded date: 2000
Investment Type: Venture Capital

Portfolio 1

DateNameWebsiteTotal RaisedLocation
18.05.2023Myeloid Th...myeloidtx....$73MUnited Sta...

Mentions in press and media 68

DateTitleDescriptionSource
23.06.2021RapidPulse Launches with $15M for Ischemic Stroke Therapy– RapidPulse, Inc., a Miami-based medical device company developing a novel aspiration system to tre...hitconsult...
15.04.2019Term Sheet — Monday, April 15FAILING THE QUIZ The latest drama out of startup-land? Of all the things, it’s a power struggle of ...fortune.co...
15.04.2019Hatteras Raises $94M For Sixth FundDURHAM, N.C., April 15, 2019 (GLOBE NEWSWIRE) — Hatteras Venture Partners announced today the first ...citybizlis...
03.01.2019Hatteras Venture Partners-backed StrideBio Appoints Sapan Sh...StrideBio, Inc, a leading developer of novel adeno-associated viral (AAV) based gene therapies, anno...citybizlis...
14.06.2018StrideBio Raises $15.7M Series AStrideBio, Inc, a US-based company developing novel AAV vectors for in vivo gene therapies announced...citybizlis...
23.04.20188VC has closed its second early-stage fund, seemingly with a...8VC, the early-stage, San Francisco-based venture firm founded in 2015 by serial entrepreneur Joe Lo...techcrunch...
19.01.2018NurseGrid raises $5.7M for scheduling and staffing tech plat...NurseGrid’s platform helps hospitals and other care providers with scheduling and staffing their nur...geekwire.c...
22.09.2017Hatteras Venture Partners Names Sir Andrew Witty as Venture ...Hatteras Venture Partners, a venture capital firm based in Research Triangle Park, N.C., named Sir A...finsmes.co...
20.09.2017Term Sheet — Wednesday, September 20THE ROBOTS ARE COMING Good morning, Term Sheet readers. Paid Content Securing the enterprise witho...fortune.co...
19.09.2017Ex-GlaxoSmithKline CEO Witty joins Hatteras as venture partn...Sir Andrew Witty has joined Hatteras Venture Partners. The former GlaxoSmithKline CEO is taking up a...fiercebiot...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In